Logotype for Sumco Corporation

Sumco (3436) Q1 2026 earnings summary

Event summary combining transcript, slides, and related documents.

Logotype for Sumco Corporation

Q1 2026 earnings summary

19 May, 2026

Executive summary

  • Q1 FY2026 net sales were ¥101.4 billion, with an operating loss of ¥5.2 billion and a net loss of ¥8.4 billion, reflecting declines due to weak non-AI demand and volume/mix effects.

  • Sequential improvement is forecast for Q2, with sales of ¥112 billion and a narrower operating loss of ¥2.5 billion, driven by higher volumes and favorable forex at ¥160/USD.

  • Strong AI-related demand continues to support 300mm wafer shipments, while 200mm and smaller wafers remain weak due to sluggish end-market demand and ongoing inventory adjustments.

  • Dividend policy remains unchanged, with an interim dividend of ¥10 per share planned, supported by retained earnings and cash flow.

Financial highlights

  • Q1 sales: ¥101.4 billion; operating loss: ¥5.2 billion; ordinary loss: ¥7.9 billion; net loss: ¥8.4 billion; basic EPS: ¥-24.22.

  • EBITDA for Q1: ¥23.4 billion; EBITDA margin: 23.1%, down year-over-year and sequentially.

  • CapEx for Q1: ¥9.4 billion; depreciation: ¥30.8 billion.

  • Q2 forecast: sales ¥112 billion, operating loss ¥2.5 billion, net loss ¥7 billion, depreciation ¥33.7 billion; EBITDA margin expected to improve to 26%.

Outlook and guidance

  • Q2 performance expected to improve sequentially due to higher volumes and yen depreciation; 300mm wafer demand for AI and DRAM projected to remain strong.

  • Non-AI and 200mm segments expected to recover gradually, but overall recovery remains slow.

  • No specific guidance on timing for return to operating profit; six-month forecast anticipates continued losses despite sales growth.

  • Facility upgrades and restructuring for 300mm and smaller wafers are ongoing.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more